Tuesday, 22 May 2018, 18h30 to 20h00, Members’ Salon ASP G0
Plenary Event “Driving innovation in health: How does Europe remain a global leader in life sciences?”
Thursday, 24 May, 16h30 to 18h30, room PHSB001
The event is kindly hosted by MEP Lieve Wierinck together with MEP Adina Valean and MEP Françoise Grossetête
The pharmaceutical industry is on the cusp of delivering ground-breaking treatments for patients. From CAR-T to cell therapies and the HIV vaccine, innovative therapies have the potential to
revolutionise patients’ lives.
During a series of “fireside chats” we will discuss the following themes:
– How collaboration in research can advance the development of treatments and accelerate patients’ access to innovative therapies
– What is the role of incentives in sustaining innovation in healthcare in Europe
– How we can further empower patients to contribute to the innovation and medicines development process
– How we can introduce future innovations into healthcare systems in a sustainable way
Two days of Workshops
Wednesday & Thursday 23 24 May, Exhibition Space, 3rd floor European Parliament
Day 1: Pharmaceutical innovations that changed our lives forever
The first day of workshops/interactive sessions will provide members with the opportunity to demonstrate some of the amazing innovations that the pharmaceutical industry have brought to market and have drastically changed patient outcomes.
9:45 – Welcome, EFPIA
10:00 – Oncology (Bayer & MSD)
11:00 – Stroke treatment, Joanne van Ryn (Senior Medical Advisor, BI International, Germany)
12:00 – Ebola vaccines, Patricia Massetti (Associate Vice President, Vaccines MSD Europe, Russia, Africa & Middle East Region)
14:00 – CART: breaking frontiers in haematology, Simona Paratore (MD, Head of Medical Cell & Gene Therapy Novartis Oncology Region Europe)
15:00 – Paediatric formulations, Alastair Coupe (Senior Director Pfizer Pharmaceuticals)
16:00 – Heart Diseases (Bayer)
Day 2: How will innovation change our medicine in the next decade?
The second day would serve to highlight the huge medical advances in the pharmaceutical pipeline that will completely change health outcomes for Europeans in the next decade. More future
focused, these workshops will aim to foster an open debate on the challenges our healthcare systems face, the opportunities for progress & how we can ensure the pharmaceutical industry has
the regulatory framework it needs in order to continue investment.
9:45 – Welcome, EFPIA
10:00 – Real World Data Platforms and Disease Interception, Martine Lewi (Scientific Director, Clinical Innovation Janssen R&D)
11:00 – Vaccines of the future (mRNA), Kim Schmidt (Senior Research Scientist CuraVac)
12:00 – UCART immunotherapy, Amina Zinaï (MD, PharmD; U-CART Project Director)
13:00 – Migraine & CGRP: A new era for patients, Jan Versijpt (Head of Headache centre at Brussels University Hospital)
14:00 – Diabetes and new therapies, Jochen Maas (General Manager R&D Sanofi Germany); Michael Attlan (New Technologies Platform Head, Sanofi France)
15:00 – Stem cell potential and tissue engineering, Diego Ardigò (Head of R&D Rare Disease Unit Head Chiesi Farmaceutici)